Ad-hoc | 14 February 2003 00:05

Carl Zeiss Meditec AG english

EBIT more than quadrupled at EUR 5,8m – Sales and profit targets confirmed Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– (Jena, 14 February 2003) In the first quarter of the 2002/2003 financial year (ending 31 December 2002) Carl Zeiss Meditec AG was able to significantly improve its profit situation. Compared to the same period last year, earnings before interest and taxes (EBIT) increased by 346% from EUR 1.3m to EUR 5.8m. The net income for the first quarter significantly increased from 0.2m EUR to 2.5m EUR. As a result, earnings per share are at EUR 0.10 (previous year: EUR 0.01). The reasons for the significant increase are to be seen in the further expansion of the already dominant market position, consolidation effects as well as realisation of the first synergies arising from the merger. The sales volume rose by 34.9% to EUR 62.4m compared to EUR 46.2m. In the course of the quarter cash assets increased from EUR 7.2m to EUR 10.0m. This is attributable to operative cash flow, that amounted to EUR 2.0m (previous year: EUR -5.5m). The equity ratio increased to 50.3% (49.2%). Carl Zeiss Meditec reaffirmes the target of about EUR 255m in sales for the current financial year and an EBIT of about EUR 20m. Contact: Carl Zeiss Meditec AG, Jens Brajer/Investor Relations, Göschwitzer Str. 51-52, D-07745 Jena, Telefon +49 (0)3641-220-105, Fax: +49 (0)3641-220-102, E-Mail: investors@meditec.zeiss.com end of ad-hoc-announcement (c)DGAP 13.02.2003 ——————————————————————————– WKN: 531370; ISIN: DE0005313704; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München und Stuttgart 140005 Feb 03